Transcatheter Embolization and Occlusion Devices – Market Insights – Latin America (Supplemental)

Although COVID-19 has negatively impacted the Latin American transcatheter embolization and occlusion device market, the impact of COVID-19 has been limited. The market will expand at a modest rate over the forecast period due largely to growing adoption of minimally invasive treatment option such as embolization and adoption of advanced TEO devices supported by favorable clinical trial results.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for TEO devices in Latin America from 2019 through 2031.

Table of contents

Transcatheter Embolization and Occlusion Devices - Market Insights - Latin America (Supplemental)

Riyona D Silva

Riyona D Silva is an associate healthcare research and data analyst on the Cardiovascular Medtech Insights team at Clarivate, specializing in the neurovascular and peripheral vascular device markets. Riyona holds a Doctor of Pharmacy degree from Manipal University.

Pankhil Gandhi, PharmD

Pankhil Gandhi is an analyst within the Cardiovascular Medtech Insights team at Clarivate, specializing in transcatheter embolization and occlusion devices and deep venous disease treatment devices markets. Pankhil holds a Doctor of Pharmacy degree from the Babasaheb Ambedkar Marathwada University, Aurangabad.

Contact sales Login to access report

Back to all Medtech Insights reports